NASDAQ:ANGO AngioDynamics (ANGO) Stock Forecast, Price & News $7.32 +0.08 (+1.10%) (As of 09/28/2023 ET) Add Compare Share Share Today's Range$7.16▼$7.4550-Day Range$7.02▼$9.0052-Week Range$6.72▼$21.88Volume408,773 shsAverage Volume454,776 shsMarket Capitalization$290.38 millionP/E RatioN/ADividend YieldN/APrice Target$17.33 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability AngioDynamics MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside136.8% Upside$17.33 Price TargetShort InterestHealthy4.86% of Float Sold ShortDividend StrengthN/ASustainability-0.99Upright™ Environmental ScoreNews Sentiment0.50Based on 12 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.33) to ($0.16) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.43 out of 5 starsMedical Sector217th out of 969 stocksSurgical & Medical Instruments Industry29th out of 100 stocks 3.5 Analyst's Opinion Consensus RatingAngioDynamics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $17.33, AngioDynamics has a forecasted upside of 136.8% from its current price of $7.32.Amount of Analyst CoverageAngioDynamics has only been the subject of 2 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted4.86% of the float of AngioDynamics has been sold short.Short Interest Ratio / Days to CoverAngioDynamics has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in AngioDynamics has recently increased by 51.64%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldAngioDynamics does not currently pay a dividend.Dividend GrowthAngioDynamics does not have a long track record of dividend growth. Previous Next 4.2 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreAngioDynamics has received a 59.93% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Ultrasound machines", "Clinical laser systems", and "Intravenous therapy equipment" products. See details.Environmental SustainabilityThe Environmental Impact score for AngioDynamics is -0.99. Previous Next 2.5 News and Social Media Coverage News SentimentAngioDynamics has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.67 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 12 news articles for AngioDynamics this week, compared to 3 articles on an average week.Search Interest2 people have searched for ANGO on MarketBeat in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, AngioDynamics insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.90% of the stock of AngioDynamics is held by insiders.Percentage Held by Institutions90.52% of the stock of AngioDynamics is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for AngioDynamics are expected to grow in the coming year, from ($0.33) to ($0.16) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of AngioDynamics is -5.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of AngioDynamics is -5.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAngioDynamics has a P/B Ratio of 0.76. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About AngioDynamics (NASDAQ:ANGO) StockAngioDynamics, Inc. provides invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology in the United States and internationally. It offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium for treatment of peripheral arterial disease. The company's thrombus management portfolio includes AlphaVac system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac circuit is indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. In addition, it offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. The company also provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.Read More ANGO Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ANGO Stock News HeadlinesSeptember 28, 2023 | americanbankingnews.comBrokers Issue Forecasts for AngioDynamics, Inc.'s Q1 2024 Earnings (NASDAQ:ANGO)September 27, 2023 | americanbankingnews.comAngioDynamics (ANGO) Scheduled to Post Earnings on WednesdaySeptember 28, 2023 | Micro-Cap Stock Trader (Ad)Unlock the treasure on Mount Olympus with this little-known mining stock.Investor Find Lithium Gold and Crush the Bear Market with 32k Metric TonsSeptember 26, 2023 | americanbankingnews.comAngioDynamics (NASDAQ:ANGO) Receives New Coverage from Analysts at HC WainwrightSeptember 25, 2023 | markets.businessinsider.comAngioDynamics - Undervalued Gem In Med Tech: Analyst Eyes Stellar Growth With A 'Buy' StanceSeptember 25, 2023 | finance.yahoo.comWhy AngioDynamics Stock Popped on MondaySeptember 25, 2023 | americanbankingnews.comHead to Head Comparison: AngioDynamics (NASDAQ:ANGO) vs. Femasys (NASDAQ:FEMY)September 17, 2023 | seekingalpha.comAngioDynamics: Enormous Effort Required In Fiscal '24 To Reverse The Equity PictureSeptember 28, 2023 | Micro-Cap Stock Trader (Ad)U.S. drive to onshore battery supply chains could create big winners in lithiumInvestor Find Lithium Gold and Crush the Bear Market with 32k Metric TonsSeptember 12, 2023 | finance.yahoo.comAngioDynamics to Report Fiscal 2024 First Quarter Financial Results on October 4, 2023September 8, 2023 | finance.yahoo.comPleasing Signs As A Number Of Insiders Buy AngioDynamics StockSeptember 7, 2023 | finance.yahoo.comAngioDynamics (ANGO) Dips More Than Broader Markets: What You Should KnowAugust 29, 2023 | finance.yahoo.comAngioDynamics (ANGO) Outpaces Stock Market Gains: What You Should KnowAugust 23, 2023 | finance.yahoo.comAngioDynamics (ANGO) Stock Sinks As Market Gains: What You Should KnowAugust 17, 2023 | finance.yahoo.comAngioDynamics (ANGO) Flat As Market Sinks: What You Should KnowAugust 16, 2023 | markets.businessinsider.comAngioDynamics Rises In Pre-market Following Approval Of Its AngioVac System For Expanded UseAugust 16, 2023 | marketwatch.comAngioDynamics Shares Up on Breakthrough Device DesignationAugust 15, 2023 | msn.comAngioDynamics gets FDA breakthrough status for AngioVac indicationAugust 15, 2023 | finance.yahoo.comAngioDynamics Receives FDA Breakthrough Device Designation for the AngioVac System for the Non-Surgical Removal of Right Heart VegetationAugust 11, 2023 | finance.yahoo.comAngioDynamics (ANGO) Gains As Market Dips: What You Should KnowAugust 3, 2023 | finance.yahoo.comAngioDynamics Completes Enrollment for PRESERVE Clinical StudyAugust 2, 2023 | msn.comAngiodynamic (ANGO) Price Target Increased by 6.45% to 16.83July 31, 2023 | finance.yahoo.comAngioDynamics to Participate in a Fireside Chat at the Canaccord Genuity Growth ConferenceJuly 25, 2023 | finance.yahoo.comShould Growth Investors Buy This Revolutionary Small-Cap Stock?July 24, 2023 | finance.yahoo.comAngioDynamics Announces Addition of Lorinda Burgess to Board of DirectorsJuly 14, 2023 | benzinga.comCanaccord Genuity Maintains Buy on AngioDynamics, Raises Price Target to $20July 14, 2023 | finance.yahoo.comAngioDynamics, Inc. (NASDAQ:ANGO) Q4 2023 Earnings Call TranscriptSee More Headlines Receive ANGO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AngioDynamics and its competitors with MarketBeat's FREE daily newsletter. Email Address ANGO Company Calendar Last Earnings7/12/2023Today9/28/2023Next Earnings (Confirmed)10/04/2023Fiscal Year End5/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNASDAQ:ANGO CUSIP03475V10 CIK1275187 Webwww.angiodynamics.com Phone(518) 795-1400Fax518-795-1401Employees815Year Founded1988Price Target and Rating Average Stock Price Forecast$17.33 High Stock Price Forecast$20.00 Low Stock Price Forecast$13.00 Forecasted Upside/Downside+135.5%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($1.32) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-52,440,000.00 Net Margins-15.48% Pretax Margin-16.07% Return on Equity-0.61% Return on Assets-0.44% Debt Debt-to-Equity Ratio0.13 Current Ratio1.95 Quick Ratio1.29 Sales & Book Value Annual Sales$338.75 million Price / Sales0.86 Cash Flow$1.11 per share Price / Cash Flow6.65 Book Value$9.64 per share Price / Book0.76Miscellaneous Outstanding Shares39,670,000Free Float37,727,000Market Cap$291.97 million OptionableOptionable Beta0.61 Social Links Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. James C. Clemmer (Age 59)CEO, Pres & Director Comp: $1.51MMr. Stephen A. Trowbridge (Age 49)Exec. VP & CFO Comp: $709.57kMr. David D. Helsel (Age 59)Sr. VP of Global Operations and R&D Comp: $573.85kMr. Chad T. Campbell (Age 52)Sr. VP and GM of Vascular Access & Oncology Global Bus. Unit Comp: $544.19kMs. Laura Piccinini (Age 54)Sr. VP & GM of International Comp: $634.52kMr. Benjamin H. Davis (Age 59)Sr. VP of Bus. Devel. Ms. Marna I. Bronfen-Moore (Age 56)Sr. VP of HR Mr. Warren G. Nighan (Age 54)Sr. VP of Quality & Regulatory Affairs Ms. Kim L. Seabury (Age 56)Sr. VP of Information Technology Mr. Scott Centea (Age 44)Sr. VP & GM of Endovascular Therapies More ExecutivesKey CompetitorsAccurayNASDAQ:ARAYSurmodicsNASDAQ:SRDXOrthofix MedicalNASDAQ:OFIXOrchestra BioMedNASDAQ:OBIOCerusNASDAQ:CERSView All CompetitorsInsiders & InstitutionsNuveen Asset Management LLCBought 78,438 shares on 8/16/2023Ownership: 1.279%Segall Bryant & Hamill LLCSold 7,601 shares on 8/15/2023Ownership: 1.528%Alliancebernstein L.P.Bought 4,380 shares on 8/15/2023Ownership: 0.107%Wells Fargo & Company MNBought 6,676 shares on 8/15/2023Ownership: 0.042%Citadel Advisors LLCSold 9,600 shares on 8/15/2023Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions ANGO Stock - Frequently Asked Questions Should I buy or sell AngioDynamics stock right now? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AngioDynamics in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ANGO shares. View ANGO analyst ratings or view top-rated stocks. What is AngioDynamics' stock price forecast for 2023? 3 analysts have issued 1 year price targets for AngioDynamics' shares. Their ANGO share price forecasts range from $13.00 to $20.00. On average, they expect the company's stock price to reach $17.33 in the next twelve months. This suggests a possible upside of 135.5% from the stock's current price. View analysts price targets for ANGO or view top-rated stocks among Wall Street analysts. How have ANGO shares performed in 2023? AngioDynamics' stock was trading at $13.77 on January 1st, 2023. Since then, ANGO stock has decreased by 46.6% and is now trading at $7.36. View the best growth stocks for 2023 here. Are investors shorting AngioDynamics? AngioDynamics saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 1,850,000 shares, an increase of 51.6% from the August 31st total of 1,220,000 shares. Based on an average daily trading volume, of 650,100 shares, the short-interest ratio is currently 2.8 days. Approximately 4.9% of the shares of the stock are short sold. View AngioDynamics' Short Interest. When is AngioDynamics' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, October 4th 2023. View our ANGO earnings forecast. How can I listen to AngioDynamics' earnings call? AngioDynamics will be holding an earnings conference call on Wednesday, October 4th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-6671 with passcode "13741149". How were AngioDynamics' earnings last quarter? AngioDynamics, Inc. (NASDAQ:ANGO) posted its quarterly earnings results on Wednesday, July, 12th. The medical instruments supplier reported $0.02 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.02. The medical instruments supplier earned $91.10 million during the quarter, compared to analysts' expectations of $90.73 million. AngioDynamics had a negative net margin of 15.48% and a negative trailing twelve-month return on equity of 0.61%. The business's quarterly revenue was up 4.7% on a year-over-year basis. During the same period in the prior year, the company earned $0.01 EPS. What guidance has AngioDynamics issued on next quarter's earnings? AngioDynamics issued an update on its FY 2024 earnings guidance on Thursday, July, 13th. The company provided EPS guidance of -$0.34--$0.28 for the period, compared to the consensus EPS estimate of -$0.02. The company issued revenue guidance of $328.00 million-$333.00 million, compared to the consensus revenue estimate of $353.62 million. What is James C. Clemmer's approval rating as AngioDynamics' CEO? 34 employees have rated AngioDynamics Chief Executive Officer James C. Clemmer on Glassdoor.com. James C. Clemmer has an approval rating of 50% among the company's employees. This puts James C. Clemmer in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. 47.0% of employees surveyed would recommend working at AngioDynamics to a friend. What other stocks do shareholders of AngioDynamics own? Based on aggregate information from My MarketBeat watchlists, some companies that other AngioDynamics investors own include General Electric (GE), Intel (INTC), Oasis Petroleum (OAS), Advanced Micro Devices (AMD), Freeport-McMoRan (FCX), Amicus Therapeutics (FOLD), Rigel Pharmaceuticals (RIGL), Accuray (ARAY), Celldex Therapeutics (CLDX) and Chimerix (CMRX). What is AngioDynamics' stock symbol? AngioDynamics trades on the NASDAQ under the ticker symbol "ANGO." Who are AngioDynamics' major shareholders? AngioDynamics' stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (18.62%), Dimensional Fund Advisors LP (5.35%), State Street Corp (4.51%), Victory Capital Management Inc. (3.67%), The Manufacturers Life Insurance Company (2.29%) and Paradigm Capital Management Inc. NY (2.05%). Insiders that own company stock include Chad Thomas Campbell, Dave Helsel, James C Clemmer, James C Clemmer, Scott Centea, Stephen A Trowbridge and Wesley Johnson. View institutional ownership trends. How do I buy shares of AngioDynamics? Shares of ANGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is AngioDynamics' stock price today? One share of ANGO stock can currently be purchased for approximately $7.36. How much money does AngioDynamics make? AngioDynamics (NASDAQ:ANGO) has a market capitalization of $291.97 million and generates $338.75 million in revenue each year. The medical instruments supplier earns $-52,440,000.00 in net income (profit) each year or ($1.32) on an earnings per share basis. How many employees does AngioDynamics have? The company employs 815 workers across the globe. Does AngioDynamics have any subsidiaries? The following companies are subsidiares of AngioDynamics: AngioDynamics Canada Inc., AngioDynamics France SARL, AngioDynamics Medical Brasil Participacoes Ltda., AngioDynamics Netherlands B. V., AngioDynamics UK Limited, AngioDynamics VA LLC, Clinical Devices, Eximo Medical Ltd., FlowMedica, NM Holding Company Inc., Navilyst Medical Holdings Inc., Navilyst Medical Inc., Oncovionic, RITA Medical Systems, RITA Medical Systems LLC, RadiaDyne LLC, and Vortex Medical.Read More How can I contact AngioDynamics? AngioDynamics' mailing address is 14 PLAZA DRIVE, LATHAM NY, 12110. The official website for the company is www.angiodynamics.com. The medical instruments supplier can be reached via phone at (518) 795-1400, via email at mpolyviou@evcgroup.com, or via fax at 518-795-1401. This page (NASDAQ:ANGO) was last updated on 9/28/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AngioDynamics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.